Cellular Treatment Insights

Brigham explains the concept of heterochronic parabiosis, emphasizing the importance of mRNA as a biological blueprint rather than a vaccine. He highlights the potential of using healthy, umbilical cord-derived cells for regenerative treatments, noting a success rate exceeding 90%. The conversation delves into the nuances of dosage and the body's natural healing signals, offering a fresh perspective on cellular therapies.